Activation of amygdala cholecystokinin(B) receptors potentiates the acoustic startle response in the rat

Journal of Neuroscience

Volumn 17, Issue 5, 1997, Pages 1838-1847

  Frankland, Paul W ^a,c   Josselyn, Sheena A ^a   Bradwejn, Jacques ^b   Vaccarino, Franco J ^a,b   Yeomans, John S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

anxiety; cholecystokinin; fear; i.c.v.; L 365,260; locomotor activity; microinjection; PD 135158; pentagastrin; startle; striatum

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; PD 135158; PENTAGASTRIN; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ RECEPTOR; DRUG DERIVATIVE; INDOLE DERIVATIVE; MEGLUMINE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEAR; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX; ANIMAL; AUDITORY STIMULATION; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ACOUSTIC STIMULATION; AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZODIAZEPINONES; CORPUS STRIATUM; FEAR; INDOLES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MEGLUMINE; NUCLEUS ACCUMBENS; PENTAGASTRIN; PHENYLUREA COMPOUNDS; RATS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; STARTLE REACTION;

EID: 0030614477     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-05-01838.1997     Document Type: Article

References (63)

1. Belcheva I, Belcheva S, Petkov VV, Petkov VD (1994) Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala. Neuropharmacology 33:995-1002.
2. Benkeltat C, Bradwejn J, Meyer E, Ellenbogen M, Milot S, Gjedde A, Evans A (1995) Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 152:1180-1184.
3. Cassella JV, Davis M (1986) The design and calibration of a startle measurement system. Physiol Behav 36:377-383.
4. Chen I-W, Dorley JM, Ramjit HG, Pitzenberger SM, Lin JH (1992) Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals. Drug Metab Dispos 20:390-395.
5. Davis M (1979) Diazepam and flurazepam: Effects on conditioned fear as measured with potentiated startle paradigm. Psychopharmacology 62:1-7.
6. Davis M (1992) The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15:353-375.
7. Davis M, Gendelman DS, Tischler M, Gendelman PM (1982) A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 2:791-805.
8. Davis M, Falls WA, Campeau S, Kim M (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58:175-198.
9. Emson PC, Rehfeld JF, Rossor MN (1982) Distribution of cholecystokinin-like peptides in the human-brain. J Neurochem 38:1177-1179.
10. Fendt M, Koch M, Schnitzler H-U (1994a) Amygdaloid noradrenaline is involved in the sensitization of the acoustic startle response in rats. Pharmacol Biochem Behav 48:307-314.
11. Fendt M, Koch M, Schnitzler H-U (1994b) Lesions of the central gray block the sensitization of the acoustic startle response in rats. Brain Res 661:163-173.
12. Fendt M, Koch M, Kungel M, Schnitzler H-U (1995) Cholecystokinin enhances the acoustic startle response in rats. NeuroReport 6:2081-2084.
13. Fendt M, Koch M, Schnitzler H-U (1996) Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm. Behav Brain Res 74:127-134.
14. Frankland PW, Yeomans JS (1995) Fear-potentiated startle and electrically evoked startle mediated by synapses in the rostrolateral midbrain. Behav Neurosci 109:669-680.
15. Frankland PW, Scott BS, Yeomans JS (1995) Axons and synapses mediating electrically evoked startle: collision tests and latency analysis. Brain Res 670:97-111.
16. B receptor agonist, pentagastrin, potentiates acoustic startle. Brain Res 733:129-132.
17. 3H]pentagastrin. Peptides 4:755-762.
18. Grillon C, Ameli R, Goddard A, Woods SW, Davis M (1994) Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 35:431-439.
19. Harro J, Vasar E, Bradwejn J (1993) ) CCK in animal and human research on anxiety. Trends Pharmacol Sci 14: 244-249.
20. Harro J, Vasar E (1991) Cholecystokinin-induced anxiety. How is it reflected in studies on exploratory behavior? Neurosci Biobehav Rev 15:473-477.
21. Hitchcock J, Davis M (1991) The efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105:826-842.
22. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN (1990) Development of a class of selective cholecystokinin type-B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728-6732.
23. Ingram SM, Krause II RG, Baldino Jr F, Skeen LC, Lewis ME (1989) Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J Comp Neurol 287:260-272.
24. Innis RB, Snyder SN (1980) Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides. Eur J Pharmacol 65:123-124.
25. B antagonist, L-365,260, attenuates fear-potentiated startle. Peptides 7:1313-1315.
26. B agonist, pentagastrin, produces a facilitation of the acoustic startle reflex. Soc Neurosci Abstr 21:1697.
27. Kapp BS, Frysinger RC, Gallagher M, Haselton JR (1979) Amygdala central nucleus lesions: effects on heart rate conditioning in the rabbit. Physiol Behav 23:1109-1117.
28. Kenne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology (Berl) 94:8-13.
29. Kim JJ, Rison RA, Fanselow MS (1993) Effects of amygdala, hippocampus, and periaqueductal gray lesions on short-and long-term contextual fear. Behav Neurosci 107:1093-1098.
30. Koch M (1993) Microinjections of the metabotropic glutamate receptor agonist, trans-(±)-1-amino-cyclopentane-1,3-dicarboxylate (trans-ACPD), into the amygdala increase the acoustic startle response of rats. Brain Res 629:176-179.
31. Koch M, Lingenhöhl K, Pilz PKD (1992) Loss of the acoustic startle response after neurotoxic lesions of the caudal pontine reticular formation: possible role of giant neurons. Neuroscience 49:617-625.
32. Krase W, Koch M, Schnitzler H-U (1994) Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats. Behav Brain Res 63:81-88.
33. Kungel M, Ebert U, Herbert H, Ostwald J (1994) Substance P and other putative transmitters modulate the activity of reticular pontine neurons: an electrophysiological and immunohistochemical study. Brain Res 643:29-39.
34. Larssen LI, Rehfeld JF (1979) Localization of molecular and heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res 165:201-218.
35. LeDoux JE, Iwata J, Cicchetti P, Reis DJ (1988) Different projections of the central amygdaloid nucleus mediate autonomie and behavioral correlates of conditioned fear. J Neurosci 8:2517-2529.
36. Lee Y, Davis M (1996) The role of the bed nucleus of the stria terminalis in CRH-enhanced startle: an animal model of anxiety. Soc Neurosci Abstr 22:465.
37. Lee Y, López DE, Meloni EG, Davis M (1996) A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci 16:3775-3789.
38. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M (1992) Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 12:2303-2312.
39. Lin JH, Storey DE, Chen I-W, Xu X (1996) Improved oral absorption of L-365,260, a poorly soluble drug. Biopharmacol Drug Dispos 17:1-15.
40. Lingenhöhl K, Friauf E (1992) Giant neurons in the caudal pontine reticular formation receive short latency acoustic input: an intracellular recording and HRP-study in the rat. J Comp Neurol 325:473-492.
41. Lingenhöhl K, Friauf E (1994) Giant neurons in the rat reticular formation: a sensorimotor interface in the elementary acoustic startle circuit? J Neurosci 14:1176-1194.
42. B receptors in behavioral and hormonal studies in rats. Naunyn Schmiedebergs Arch Pharmacol 349:478-484.
43. McDonald AJ (1985) Morphology of peptide-containing neurons in the rat basolateral amygdaloid nucleus. Brain Res 338:186-191.
44. Moran TH, Robinson PH, Goldrich MS, McHugh PR (1986) Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362:175-179.
45. Patrick CJ, Berthot BD, Moore JD (1996) Diazepam blocks fear-potentiated startle in humans. J Abnorm Psychol 105:89-96.
46. Pavlasevic S, Bednar I, Qureshi GA, Soderste P (1993) Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. NeuroReport 5:225-228.
47. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd Ed. San Diego: Academic.
48. Plappert CF, Pilz PK, Schnitzler H-U (1993) Acoustic startle response and habituation in freezing and nonfreezing rats. Behav Neurosci 107:981-987.
49. Pu S, Zhuang H, Lu Z, Wu X, Han J (1994) Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance. Brain Res Mol Brain Res 21:183-189.
50. Pratt JA, Brett RR (1995) The benzodiazepine receptor inverse agonist FG7142 induces cholecystokinin gene expression in the rat brain. Neurosci Lett 184:197-200.
51. B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. NeuroReport 5:154-156.
52. Rataud J, Darche F, Piot O, Stutzmann J-M, Böhme GA, Blanchard J-C (1991) "Anxiolytic" effect of CCK-antagonists on plus maze behavior in mice. Brain Res 548:315-317.
53. Rex A, Barth T, Voigt J-P, Domeney AM, Fink H (1994) Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci Lett 172:139-142.
54. Rosen JB, Hitchcock JM, Sananes CB, Miserendino MJD, Davis M (1991) A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci 105:817-825.
55. Saito A, Goldfine ID, Williams JA (1980) Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex. J Neurochem 37:433-490.
56. Schiffmann SN, Vanderhaeghen JJ (1991) Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J Comp Neurol 304:219-233.
57. Singh L, Field MJ, Hughes J, Vass CA, Woodruff ON (1991) The behavioral properties of CI-988, a selective cholecystokinin-B receptor antagonist. Br J Pharmacol 104:239-245.
58. Vanderhaeghen JJ (1985) Neuronal cholecystokinin. In: Handbook of chemical neuroanatomy, Vol 4, GABA and neuropeptides in the CNS (Björklund A, Hökfelt T, eds), pp 406-435. Amsterdam: Elsevier.
59. Vanderhaeghen JJ, Signeau JC, Gepts W (1975) New peptide in the vertebrate CNS reacting with anti-gastrin antibodies. Nature 257:604-605.
60. Wecker JR, Ison JR (1986) Effects of motor activity on the elicitation and modification of the startle reflex in rats. Anim Learn Behav 14:287-292.
61. Yeomans JS, Frankland PW (1996) The acoustic startle reflex: neurons and connections. Brain Res Rev 21:301-314.
62. Yeomans JS, Pollard BA (1993) Amygdala efferents mediating electrically evoked startle-like responses and fear potentiation of acoustic startle. Behav Neurosci 107:596-610.
63. Zhou Y, Arifuzzaman AI, Josselyn SA, Frankland PW, Bradwejn J, Vaccarino FJ (1996) Effects of intraperitoneal administration of CCK agonist and antagonist on acoustical startle response, an anxiety model, in rats. Soc Neurosci Abstr 22:1153.